Robert Rosen, President & CCO at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 100,000 shares at $23.21 ($2.3M) on 2016-08-10, disclosed to the SEC on 2016-08-12.
Open-market sale of $2.3M HRTX by President & CCO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.21 | 87,600 | $2.0M | 87.3% |
| 2 | $23.89 | 12,400 | $296K | 12.7% |
| Total | $23.29 avg | 100,000 | $2.3M | 100% |
| Filing → |
| HRTX | SELL | 2016-08-12 | $296K | — | Filing → |
| HRTX | SELL | 2016-04-21 | $436K | — | Filing → |
| HRTX | SELL | 2016-04-21 | $4.1M | — | Filing → |